First-of-a-kind surgery in US for severe headaches

August 18, 2014
Surgeons at The Ohio State University Wexner Medical Center insert the nation's first neurostimulator designed to treat severe headaches known as cluster headaches. The tiny neurostimulator, which is attached to a patient`s cheekbone, has a wire that feeds directly into the nerves that are associated with cluster headaches. Once in place, patients use a hand-held device to activate the neurostimulator and `turn off`the pain they get from cluster headaches. Credit: The Ohio State University Wexner Medical Center

For those suffering excruciating pain from cluster headaches, relief may soon be available from an investigational device being studied in a national multicenter clinical trial. Recently, doctors at The Ohio State University Wexner Medical Center performed the first surgery in the United States to insert a neurostimulator to provide relief from cluster headaches, which are more painful than migraines. "Cluster headache is one of the most severe and disabling chronic pain conditions known to humankind. That's why it's important to look at options to help these patients," said Dr. Ali Rezai, director of the Neuroscience program at Ohio State's Wexner Medical Center and one of the scientific developers of this technology.

During the outpatient surgery, sinus surgeon Dr. Bradley Otto and oral surgeon Dr. Peter Larsen inserted the device through a small incision in the patient's gum into the side of the face affected by cluster headaches. Autonomic Technologies Inc. developed the miniaturized, multi­channel peripheral nerve stimulator, which is smaller than an almond, to stimulate the sphenopalatine ganglion (SPG). The SPG is a nerve bundle located behind the nose and is known to play a major role in severe headaches.

"Through an incision about 2 centimeters long, we're able to place this device, then pass it around the back of the maxillary sinus, or the cheek sinus, into this area where this ganglion is situated," said Larsen, who is professor of oral and maxillofacial surgery in the College of Dentistry at Ohio State. "The device is very small, and the patient doesn't even sense that it's there."

When patients begin to feel a starting, they hold the rechargeable handheld remote controller to their cheek to activate the stimulator to block the . The patient's physician can program the device to give the appropriate length and strength of stimulation.

A tiny, experimental neurostimulator, like this one, is being tested for the first time in patients in the US to treat cluster headaches. Doctors at The Ohio State University Wexner Medical Center say the neurostimulator has a wire (not visible) that feeds into the nerves behind the sinus cavity, which are associated with cluster headaches. A hand-held device is used to activate the stimulator and 'short circuit' the pain signals. Credit: The Ohio State University Wexner Medical Center

"This nerve control center sits behind the cheek sinus and is involved in the transmission pathway of cluster headache," said Otto, who is director of rhinology in the Department of Otolaryngology at Ohio State. "And so by blocking or short­circuiting that involvement, we think it will help treat cluster headache. The beauty of the device is that there are no internal batteries or other structures that need to be routinely removed. So, once we make the incision in the mouth and we place this device back behind the cheek sinus, it can be left forever."

The video will load shortly
During a recent operation, surgeons at The Ohio State University Wexner Medical Center became the first in the United States to insert a tiny neurostimulator into a patient`s cheekbone, in an effort to treat his cluster headaches. This is the first of 120 surgeries that will take place in this multi-center trial over the next few years. Credit: The Ohio State University Wexner Medical Center

It's estimated that nearly 400,000 people in the United States suffer from cluster headache, which can happen many times each day, with each one lasting from 15 minutes to three hours. Cluster headache is often called "suicide headache" because the is so intense. Cluster headaches typically involve one side of the head, and are much more common in men. The headaches are so severe that they cause very disabling sharp and stabbing pain around and in the affected eye, along with pain in the nose, head and temple. Drooping eyelids, redness and tearing often accompany the eye pain, and there is no cure. "SPG interventions have been around for the past 100 years," said Rezai, including using anesthetics to block the SPG to surgical procedures to cut the SPG or chemically burning it. ""The main advantage of neurostimulation is that it's reversible and adjustable, and you're just modulating and blocking the pain signals."

In all, up to 120 patients with cluster headaches will receive the experimental device as part of the multi­center clinical trial that will last several years.

Explore further: Season's change can bring on cluster headaches

Related Stories

Botox to treat 'suicide' headaches

November 1, 2013

"I hit myself in the head to distract myself from the pain when I have a cluster headache. The pain is indescribable hell, and in desperate moments, I have hit my head against a brick wall and hit myself in the head with ...

Surgery doubted as a migraine reliever

June 27, 2014

(HealthDay)—Migraine surgery is increasingly touted as a potential "cure" for the debilitating headaches, but researchers say the evidence just isn't there to support those claims.

Recommended for you

3-D bioprinted human cartilage cells can be implanted

March 23, 2017

Swedish researchers at Sahlgrenska Academy and Chalmers University of Technology have successfully induced human cartilage cells to live and grow in an animal model, using 3-D bioprinting. The results will move development ...

MRI-powered mini-robots could offer targeted treatment

March 7, 2017

Invasive surgical techniques - cutting through the breastbone for open heart surgery or making a large incision to inspect an abdominal tumor - allow physicians to effectively treat disease but can lead to sometimes serious ...

New method rescues donor organs to save lives

March 6, 2017

A multidisciplinary team led by Gordana Vunjak-Novakovic, Mikati Foundation Professor of Biomedical Engineering and Medical Sciences at Columbia Engineering, and Matt Bacchetta, associate professor of surgery at Columbia ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.